Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.00
Bid: 131.55
Ask: 131.65
Change: 1.85 (1.42%)
Spread: 0.10 (0.076%)
Open: 130.35
High: 132.20
Low: 128.95
Prev. Close: 130.15
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Centrica announces final results of tender offer

20 May 2024 11:18

RNS Number : 1163P
Centrica PLC
20 May 2024
 

Centrica plc

(the "Company")

announces the results of its Tender Offer for its Subordinated Resettable Fixed Rate Notes due 2075

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (the "UNITED STATES") OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA").

20 May 2024. The Company announces today the results of its invitation (the "Offer") to holders of its outstanding £450,000,000 Subordinated Resettable Fixed Rate Notes due 2075 (ISIN: XS1216019585) (the "Notes"), to tender their Notes for purchase by the Company for cash, subject to the conditions described in the tender offer memorandum dated 10 May 2024 (the "Tender Offer Memorandum"), and subject to the offer restrictions set out in the Tender Offer Memorandum.

Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offer was 4.00 p.m. (London time) on 17 May 2024. As at the Expiration Deadline, £414,693,000 in aggregate principal amount of the Notes was validly tendered for purchase in the Offer.

The Company hereby announces that (subject to the satisfaction, or waiver, of the New Financing Condition on or prior to the Settlement Date) it has decided to accept for purchase £414,693,000 in aggregate principal amount of the Notes validly tendered pursuant to the Offer.

Accrued Interest will also be payable in respect of any Notes accepted for purchase pursuant to the Offer.

Following the Settlement Date, the Company intends to cancel the Notes purchased pursuant to the Offer and, accordingly, the Company will have repurchased and cancelled 92.15 per cent. of the nominal amount of the Notes. As a consequence, the 80 per cent. threshold as described in the Tender Offer Memorandum will have been met and it is the current intention of the Company to exercise its option under the terms and conditions of the Notes to redeem, following settlement of the Offer, all of the Notes that were not validly tendered and accepted for purchase pursuant to the Offer, at their principal amount together with any accrued and unpaid interest (including any outstanding Arrears of Interest (as defined in the terms and conditions of the Notes)) up to (but excluding) the redemption date. However, the Company is not under any obligation to make any such redemption and the Company's intention to do so may change at any time and for various factors existing at that time.

Settlement

Settlement of the Offer and payment of the Purchase Price and Accrued Interest in respect of the Notes accepted for purchase pursuant to the Offer is expected to take place on 22 May 2024.

£35,307,000 in aggregate principal amount of the Notes will remain outstanding after the Settlement Date.

Full details concerning the Offer are set out in the Tender Offer Memorandum.

Barclays Bank PLC and J.P. Morgan Securities plc are acting as the Dealer Managers for the Offer and Kroll Issuer Services Limited is acting as the Tender Agent, and their contact details are set out below.

 

DEALER MANAGERS

Barclays Bank PLC

1 Churchill Place

London E14 5HP

United Kingdom

 

 

Telephone: +44 20 3134 8515

Attention: Liability Management Group

Email: eu.lm@barclays.com

J.P. Morgan Securities plc

25 Bank Street

Canary Wharf

London E14 5JP

United Kingdom

 

Telephone: +44 20 7134 2468

Attention: EMEA Liability Management Group

Email: liability_management_EMEA@jpmorgan.com

TENDER AGENT

Kroll Issuer Services Limited

The Shard

32 London Bridge Street

London SE1 9SG

United Kingdom

 

Telephone: +44 20 7704 0880

Attention: Alessandro Zorza

Email: centrica@is.kroll.com

Offer Website: https://deals.is.kroll.com/centrica

This announcement is made by Centrica plc and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA ("UK MAR"), encompassing information relating to the results of the Offer. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Raj Roy, Company Secretary at Centrica plc.

 

DISCLAIMER Subject to applicable law, the Company or any of its affiliates may at any time following completion of the Offer purchase remaining outstanding Notes by tender, in the open market, by private agreement or otherwise on such terms and at such prices as the Company, or if applicable, its affiliates may determine. Such terms, consideration and prices may be more or less favourable than those offered pursuant to the Offer.

This announcement must be read in conjunction with the Tender Offer Memorandum. If any Noteholder is in any doubt as to the content of this announcement or the Tender Offer Memorandum or the action it should take, it is recommended to seek its own financial advice, including in respect of any tax consequences, from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser.

The distribution of this announcement and/or the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions. Neither this announcement nor the Tender Offer Memorandum constitutes an offer to buy or the solicitation of an offer to sell Notes or an invitation to participate in the Offer. The Offer has now expired.

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENAMMMTMTBTBRI
Date   Source Headline
14th Jun 20246:00 pmRNSTransaction in Own Shares
13th Jun 20246:00 pmRNSTransaction in Own Shares
12th Jun 20246:00 pmRNSTransaction in Own Shares
12th Jun 202411:17 amRNSCentrica announces final results of Tender Offer
12th Jun 20247:00 amRNSCentrica Tender Offer – Indicative Results
11th Jun 20246:00 pmRNSTransaction in Own Shares
11th Jun 20243:30 pmRNSDirector/PDMR Shareholding
10th Jun 20246:24 pmRNSTransaction in Own Shares
7th Jun 20246:00 pmRNSTransaction in Own Shares
6th Jun 20246:00 pmRNSTransaction in Own Shares
5th Jun 20246:15 pmRNSTransaction in Own Shares
5th Jun 20242:30 pmRNSResult of AGM
5th Jun 20247:00 amRNSAGM Statement
4th Jun 20246:00 pmRNSTransaction in Own Shares
4th Jun 20249:07 amRNSCentrica announces tender offer
3rd Jun 20246:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20246:00 pmRNSTransaction in Own Shares
3rd Jun 20244:00 pmRNSTotal Voting Rights
3rd Jun 20247:28 amRNSTransaction in Own Shares
3rd Jun 20247:28 amRNSCancellation of treasury shares
30th May 20246:00 pmRNSTransaction in Own Shares
30th May 20244:45 pmRNSPublication of a Prospectus
29th May 20246:00 pmRNSTransaction in Own Shares
28th May 20246:00 pmRNSTransaction in Own Shares
28th May 20243:00 pmRNSDirector/PDMR Shareholding
24th May 20246:00 pmRNSTransaction in Own Shares
23rd May 20246:00 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20246:00 pmRNSTransaction in Own Shares
22nd May 202412:32 pmRNSNotice of redemption of remaining hybrid bonds
21st May 20246:00 pmRNSTransaction in Own Shares
21st May 20243:30 pmRNSDirector Declaration
20th May 20246:15 pmRNSTransaction in Own Shares
20th May 202411:18 amRNSCentrica announces final results of tender offer
17th May 20246:00 pmRNSTransaction in Own Shares
17th May 20245:00 pmRNSDirector/PDMR Shareholding
17th May 20242:00 pmRNSPublication of a Prospectus
16th May 20246:00 pmRNSTransaction in Own Shares
15th May 20246:00 pmRNSTransaction in Own Shares
15th May 20244:18 pmRNSDirector Declaration
15th May 20249:04 amRNSStabilisation Notice
14th May 20246:10 pmRNSTransaction in Own Shares
14th May 202412:16 pmRNSStabilisation Notice
14th May 20248:59 amRNSStabilisation Notice
13th May 20246:15 pmRNSTransaction in Own Shares
13th May 20246:15 pmRNSDirector/PDMR Shareholding
10th May 20246:00 pmRNSTransaction in Own Shares
10th May 20249:07 amRNSCentrica announces new issue and tender offer
9th May 20246:00 pmRNSTransaction in Own Shares
8th May 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.